BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30006142)

  • 1. The genome-wide sequence specificity of DNA cleavage by bleomycin analogues in human cells.
    Murray V; Chen JK; Yang D; Shen B
    Bioorg Med Chem; 2018 Aug; 26(14):4168-4178. PubMed ID: 30006142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zorbamycin has a different DNA sequence selectivity compared with bleomycin and analogues.
    Chen JK; Yang D; Shen B; Neilan BA; Murray V
    Bioorg Med Chem; 2016 Nov; 24(22):6094-6101. PubMed ID: 27745992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin analogues preferentially cleave at the transcription start sites of actively transcribed genes in human cells.
    Chen JK; Yang D; Shen B; Murray V
    Int J Biochem Cell Biol; 2017 Apr; 85():56-65. PubMed ID: 28167289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genome-wide DNA sequence specificity of the anti-tumour drug bleomycin in human cells.
    Murray V; Chen JK; Tanaka MM
    Mol Biol Rep; 2016 Jul; 43(7):639-51. PubMed ID: 27188426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A designer bleomycin with significantly improved DNA cleavage activity.
    Huang SX; Feng Z; Wang L; Galm U; Wendt-Pienkowski E; Yang D; Tao M; Coughlin JM; Duan Y; Shen B
    J Am Chem Soc; 2012 Aug; 134(32):13501-9. PubMed ID: 22831455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitochondrial DNA sequence specificity of the anti-tumour drug bleomycin using end-labeled DNA and capillary electrophoresis and a comparison with genome-wide DNA sequencing.
    Chung LH; Murray V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():87-97. PubMed ID: 26638033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.
    Wassermann K; Zwelling LA; Lown JW; Hartley JA; Nishikawa K; Lin JR; Newman RA
    Cancer Res; 1990 Mar; 50(6):1732-7. PubMed ID: 1689610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA sequence specificity of bleomycin cleavage in a systematically altered DNA sequence.
    Gautam SD; Chen JK; Murray V
    J Biol Inorg Chem; 2017 Aug; 22(6):881-892. PubMed ID: 28509989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interaction of the Metallo-Glycopeptide Anti-Tumour Drug Bleomycin with DNA.
    Murray V; Chen JK; Chung LH
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29734689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The determination of the DNA sequence specificity of bleomycin-induced abasic sites.
    Chen JK; Murray V
    J Biol Inorg Chem; 2016 Jun; 21(3):395-406. PubMed ID: 26940956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BlmB and TlmB provide resistance to the bleomycin family of antitumor antibiotics by N-acetylating metal-free bleomycin, tallysomycin, phleomycin, and zorbamycin.
    Coughlin JM; Rudolf JD; Wendt-Pienkowski E; Wang L; Unsin C; Galm U; Yang D; Tao M; Shen B
    Biochemistry; 2014 Nov; 53(44):6901-9. PubMed ID: 25299801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The disaccharide moiety of bleomycin facilitates uptake by cancer cells.
    Schroeder BR; Ghare MI; Bhattacharya C; Paul R; Yu Z; Zaleski PA; Bozeman TC; Rishel MJ; Hecht SM
    J Am Chem Soc; 2014 Oct; 136(39):13641-56. PubMed ID: 25184545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of bleomycin-mediated cleavage of a hairpin DNA library.
    Segerman ZJ; Roy B; Hecht SM
    Biochemistry; 2013 Aug; 52(31):5315-27. PubMed ID: 23834496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between sites of binding to DNA and strand cleavage for complexes of bleomycin with iron or cobalt.
    McLean MJ; Dar A; Waring MJ
    J Mol Recognit; 1989 Apr; 1(4):184-92. PubMed ID: 2483675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short DNA sequence confers strong bleomycin binding to hairpin DNAs.
    Tang C; Paul A; Alam MP; Roy B; Wilson WD; Hecht SM
    J Am Chem Soc; 2014 Oct; 136(39):13715-26. PubMed ID: 25188011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered production and evaluation of 6'-deoxy-tallysomycin H-1 revealing new insights into the structure-activity relationship of the anticancer drug bleomycin.
    Yang D; Hindra ; Dong LB; Crnovcic I; Shen B
    J Antibiot (Tokyo); 2017 Aug; ():. PubMed ID: 28831149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strand scission of deoxyribonucleic acid by neocarzinostatin, auromomycin, and bleomycin: studies on base release and nucleotide sequence specificity.
    Takeshita M; Kappen LS; Grollman AP; Eisenberg M; Goldberg IH
    Biochemistry; 1981 Dec; 20(26):7599-606. PubMed ID: 6173064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of bleomycin cleavage sites in strongly bound hairpin DNAs.
    Giroux RA; Hecht SM
    J Am Chem Soc; 2010 Dec; 132(47):16987-96. PubMed ID: 21047076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation reduces binding and cleavage by bleomycin.
    Roy B; Tang C; Alam MP; Hecht SM
    Biochemistry; 2014 Sep; 53(38):6103-12. PubMed ID: 25187079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxidized gulose moiety attenuates the pulmonary toxicity of 6'-deoxy-bleomycin Z without effect on its antitumor activity.
    Kong J; Xiong Y; Duan Y; Zhu X
    Biomed Pharmacother; 2021 Apr; 136():111222. PubMed ID: 33450497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.